Literature DB >> 8785393

The benefits and side effects of ramped hypertonic sodium dialysis.

A Levin1, M B Goldstein.   

Abstract

The effectiveness of ramped hypertonic sodium dialysis (RHSD) is controversial because of the prevalence of side effects (weight gain and hypertension). Standard dialysis (SD) was therefore compared with RHSD in a double-blind controlled crossover trial. Eleven patients who suffered from symptoms attributable to water shifts from extracellular fluid to intracellular fluid (headaches or hangover) or extracellular-fluid volume contraction (cramps or lightheadedness) and five asymptomatic patients were enrolled in the study. RHSD was individually tailored to each patient (to minimize thirst) during a 2-wk run-in period. Patients then received RHSD and SD for a period of 3 wk in randomized sequence. Outcome measures were both objective and subjective ratings on questionnaires. Significant differences were found between the two treatments, with RHSD improving specific problems (70% of lightheadedness/cramps, 100% of headaches/hangover) versus SD. Weight gain and hypertension were not different between the two treatments despite increased thirst sensation reported by 14/16.94% of patients preferred RHSD. Long-term studies in 20 different patients demonstrated the lack of increase in blood pressure or weight gain after 3 and 6 months of therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8785393     DOI: 10.1681/ASN.V72242

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  8 in total

Review 1.  Optimal dialysate sodium-what is the evidence?

Authors:  Finnian R Mc Causland; Sushrut S Waikar
Journal:  Semin Dial       Date:  2014-01-23       Impact factor: 3.455

Review 2.  Dialysate Sodium: Rationale for Evolution over Time.

Authors:  Jennifer E Flythe; Finnian R Mc Causland
Journal:  Semin Dial       Date:  2017-01-08       Impact factor: 3.455

Review 3.  Osmolality and blood pressure stability during hemodialysis.

Authors:  Anika T Singh; Finnian R Mc Causland
Journal:  Semin Dial       Date:  2017-07-09       Impact factor: 3.455

4.  Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass.

Authors:  Joanna Leigh Dunlop; Alain Charles Vandal; Janak Rashme de Zoysa; Ruvin Sampath Gabriel; Imad Adbi Haloob; Christopher John Hood; Philip James Matheson; David Owen Ross McGregor; Kannaiyan Samuel Rabindranath; David John Semple; Mark Roger Marshall
Journal:  BMC Nephrol       Date:  2013-07-15       Impact factor: 2.388

5.  Rationale and design of the Myocardial Microinjury and Cardiac Remodeling Extension Study in the Sodium Lowering in Dialysate trial (Mac-SoLID study).

Authors:  Joanna Leigh Dunlop; Alain Charles Vandal; Janak Rashme de Zoysa; Ruvin Sampath Gabriel; Lukas Mathias Gerber; Imad Adbi Haloob; Christopher John Hood; John Hamilton Irvine; Philip James Matheson; David Owen Ross McGregor; Kannaiyan Samuel Rabindranath; John Benedict William Schollum; David John Semple; Mark Roger Marshall
Journal:  BMC Nephrol       Date:  2014-07-21       Impact factor: 2.388

6.  Dialysis recovery time: associated factors and its association with quality of life of hemodialysis patients.

Authors:  Mohamed Mamdouh Elsayed; Montasser Mohamed Zeid; Osama Mohamed Refai Hamza; Noha Mohamed Elkholy
Journal:  BMC Nephrol       Date:  2022-09-01       Impact factor: 2.585

7.  Low dialysate sodium levels for chronic haemodialysis.

Authors:  Joanna L Dunlop; Alain C Vandal; Mark R Marshall
Journal:  Cochrane Database Syst Rev       Date:  2019-01-16

Review 8.  Optimizing haemodialysate composition.

Authors:  Francesco Locatelli; Vincenzo La Milia; Leano Violo; Lucia Del Vecchio; Salvatore Di Filippo
Journal:  Clin Kidney J       Date:  2015-08-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.